27th April 2020
Pamir Law Group
On 31 March 2020, China issued the “Notice Regarding Orderly Development of Medical Goods Exports applicable to the exports of Private Protective Equipment (“PPE”)”, effective 1 April 2020 (the “Notice”). MSI's Taiwan law member Pamir Law Group provides further information.
The Notice is intended to insure the quality of PPE by requiring that Chinese manufacturers of PPE have proper certifications by the State Food and Drug Administration (“SFDA”) and that the manufacturers be listed in the national medical products registry maintained by the SFDA.
The PPE categories covered include the following types of products for fighting coronavirus which require verification:
Special Goods”), and therefore require an Export Health and Quarantine Permit (“EHQP”) issued by the SFDA for export.
The exporter must provide the following documents before shipping to the customs office, which then coordinates with the SFDA officials to verify the contents:
The SFDA will render a decision on the EHQP to the manufacturer within 20 working days.
Download the full article on: New export requirements for ‘PPE’ in China
New headquarters for @MSI_Global in London. We recently moved our headquarters to 10 Queen Street Place at the Lon… https://t.co/sk8PY556yB
Register for our free webinar and international panel discussion on trading with the UK post Brexit. Leading accoun… https://t.co/EsDqZVlRYD
MSI's Portuguese member Moneris @RPA_Moneris launches new mobile app to help clients plan and manage #tax payments… https://t.co/yIYisFWqPm